USFDA Gives the Nod to Lupin to Market Its Suprax Capsules

by Savitha C Muppala on  July 6, 2012 at 4:43 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Drug maker Lupin announced that it has received the new drug application (NDA) approval from the US health regulator to market its Suprax capsules in the strength of 400 mg in America.
 USFDA Gives the Nod to Lupin to Market Its Suprax Capsules
USFDA Gives the Nod to Lupin to Market Its Suprax Capsules

Lupin Group President & ED Nilesh Gupta said: "The new dosage form will add to our growing Suprax franchise and gives healthcare providers and patients a new formulation to treat the indicated infections".



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive